BioCentury
ARTICLE | Clinical News

NIH begins universal flu vaccine trial

April 5, 2019 6:58 PM UTC

NIH has begun dosing subjects in a Phase I trial of its universal flu vaccine, with data readouts expected in early 2020.

The open-label, U.S. trial assessing safety and production of anti-influenza virus antibodies is enrolling at least 53 healthy volunteers and will evaluate an intramuscular injection of 20 μg H1ssF_3928 in the first five subjects and 60 μg in the remaining participants...